ライフサイエンスコーパス: vascular occlusion

1 state, resulting in neointima formation and vascular occlusion.

2 the key to hemostasis and also to pathologic vascular occlusion.

3 spectrum of IOI, retinal vasculitis, and/or vascular occlusion.

4 nt responses but can also lead to thrombotic vascular occlusion.

5 nate blood flow to preserve tissue following vascular occlusion.

6 M can be the only presenting sign of retinal vascular occlusion.

7 ciation between cataract surgery and retinal vascular occlusion.

8 exclusion of patients with proxy of retinal vascular occlusion.

9 hrombolysis in a preclinical animal model of vascular occlusion.

10 gnificantly increased in RVO and any retinal vascular occlusion.

11 The primary outcome was retinal vascular occlusion.

12 nformation like the risk level caused by any vascular occlusion.

13 apturing haemodynamic changes in response to vascular occlusion.

14 osure and secure hemostasis while preventing vascular occlusion.

15 odialysis who subsequently developed retinal vascular occlusion.

16 Rs also enhance thrombotic and nonthrombotic vascular occlusion.

17 ncy procedure in 4 patients due to prolonged vascular occlusion.

18 chemic inflammation initiates already during vascular occlusion.

19 tion, incompetent blood-retinal barrier, and vascular occlusion.

20 are ineligible for IV t-PA but have a large vascular occlusion.

21 toring blood flow to ischemic tissue after a vascular occlusion.

22 -threatening diseases that result from acute vascular occlusion.

23 were imaged before, during, and after renal vascular occlusion.

24 id adaptation of the lymphatic pump to local vascular occlusion.

25 silateral parietal cortex to ensure adequate vascular occlusion.

26 and the most common cause of acute pulmonary vascular occlusion.

27 the impact of psychological stress on acute vascular occlusion.

28 heparin may be useful in preventing painful vascular occlusion.

29 ndothelium is important to the generation of vascular occlusion.

30 rease collateral blood flow after mesenteric vascular occlusion.

31 crosis and possibly plaque rupture and acute vascular occlusion.

32 estinal viability after segmental mesenteric vascular occlusion.

33 no association between dementia and retinal vascular occlusions.

34 potentially resulting in vision-threatening vascular occlusions.

35 cellular phenotype as fibroblasts from CTEPH vascular occlusions.

36 lood-retinal barrier with or without retinal vascular occlusions.

37 inflammatory environment that culminates in vascular occlusions.

38 n of Diseases 10 codes to select for retinal vascular occlusions.

39 ed toxicities were chorioretinal atrophy and vascular occlusions.

40 M)beta(2) microdomains leads to acute lethal vascular occlusions.

41 Mice deficient in VN (n = 12) developed vascular occlusion 77 +/- 11 minutes after injury, inter

42 lial cells has been thought to contribute to vascular occlusion, a major cause of morbidity in sickle

43 s (adjusted IRR 6.11, P < 0.001) and retinal vascular occlusion (adjusted IRR 3.81, P = 0.023) were s

44 We found the hazard ratio (HR) for retinal vascular occlusion after cataract surgery was 1.23 (95%

45 Diagnosing catastrophic retinal vascular occlusion after intravitreal injections as a re

46 the association between dementia and retinal vascular occlusions after adjusting for covariates which

47 on incidence also was increased with retinal vascular occlusions (aHR, 10, 95% CI, 3.0-33), retinal v

48 OI, including retinal vasculitis and retinal vascular occlusion, also were higher, leading to study t

49 ge-related macular degeneration, and retinal vascular occlusions, among others.

50 There are 1463 individuals with retinal vascular occlusion and 500 670 individuals without.

51 larger absolute force in men causes greater vascular occlusion and accumulation of dilators, while b

52 f retinal vasculitis with or without retinal vascular occlusion and an associated risk of visual acui

53 Vascular occlusion and complex plexiform lesions are hal

54 This patient highlights the vascular occlusion and endothelial cell injury in the me

55 coherence tomography (OCT), with progressive vascular occlusion and evidence of the ischemic cascade

56 es inflammatory lung pathologic findings and vascular occlusion and hemorrhage.

57 in preclinical models of Phx with or without vascular occlusion and in donor livers.

58 urs during surgery involving renal or aortic vascular occlusion and is one of the leading causes of p

59 e report that FH(R/R) mice exhibited retinal vascular occlusion and ischemia.

60 et activation during disease states leads to vascular occlusion and ischemic damage.

61 stologic examination of the same rete showed vascular occlusion and moderate intraluminal foreign bod

62 nts with a history of retinopathy or retinal vascular occlusion and other physical or mental conditio

63 ive pulmonary vascular remodeling, including vascular occlusion and plexiform-like lesions, resemblin

64 echanism of reversing established neointimal vascular occlusion and pulmonary hypertension.

65 ment dysregulation can contribute to retinal vascular occlusion and that an anti-C5 antibody might be

66 pholipid antibodies in patients with retinal vascular occlusion and the spectrum of ophthalmologic fi

67 no significant associations between retinal vascular occlusions and dementia.

68 indicate that the connection between retinal vascular occlusions and neurodegenerative diseases causi

69 investigate the association between retinal vascular occlusions and neurodegenerative disorders that

70 systemic conditions associated with retinal vascular occlusions and offer guidelines for appropriate

71 Any retinal vascular occlusions and RVO are associated with increase

72 hypofluorescent areas, widespread peripheral vascular occlusion, and ischemia.

73 tion of endothelial VWF decreased hemolysis, vascular occlusion, and organ damage caused by TNF-induc

74 ical examination shows no objective signs of vascular occlusion, and this can lead the clinician to s

75 and transiently immediately after pulmonary vascular occlusion, and this rise was blunted significan

76 have an increased risk of developing retinal vascular occlusions, and more specifically CRAO and BRAO

77 n microscopic analysis of tumor sections for vascular occlusion; and analysis of tumor cryosections f

78 myocardial infarction, stroke and peripheral vascular occlusion are the leading causes of morbidity a

79 Acute retinal vascular occlusions are common causes of visual impairme

80 Vascular occlusions are common structural modifications

81 with needles or microcannulas, but unwanted vascular occlusions are possible.

82 lculated to compare the incidence of retinal vascular occlusions before and after COVID-19 diagnosis

83 inal artery occlusion (RAO), and any retinal vascular occlusion (both RVO and RAO).

84 is a possible co-factor in atherogenesis and vascular occlusion, but its ability to actively infect m

85 soluble TM, prevents platelet activation and vascular occlusion by clots.

86 s estimated incidence rate ratios of retinal vascular occlusion by duration, dosage, and type of horm

87 AION with visible vascular occlusion can be a rare retinal cause of acute

88 Vascular occlusion can lead to increased pressure in the

89 thus be attributed to impaired perfusion and vascular occlusion caused by deposition of Abeta and fib

90 Sickle cell disease (SCD) results in vascular occlusions, chronic hemolytic anemia, and cumul

91 frequency (24+/-2%) and severity (9+/-4%) of vascular occlusion compared with wild-type controls (n=7

92 lls into Rag2-deficient mice greatly reduced vascular occlusion compared with WT cells, clearly demon

93 athophysiology depicted with imaging include vascular occlusion, compensatory collateral flow, result

94 d to determine measurement agreement between vascular occlusion conditions.

95 In patients with persistent vascular occlusions despite intravenous tissue plasminog

96 ls in 28, umbrella devices in 6 and a Grifka vascular occlusion device in 1.

97 PEDs and resolution of PAMM, with no further vascular occlusion during corticosteroid taper.Conclusio

98 tched on age and smoking who did not develop vascular occlusion during the prospective follow-up peri

99 tified through prescription records; retinal vascular occlusion events were detected through hospital

100 ith inflamed endothelium, triggering painful vascular occlusion events.

101 he patient had no classical risk factors for vascular occlusions, except for the presence of Flammer

102 in vascular injury in sickle cell anemia, in vascular occlusion following the rupture of atherosclero

103 inal vascular occlusions, those with retinal vascular occlusions had a higher prevalence of dementia

104 gabapentin administration had no effects on vascular occlusion, haemodynamic changes nor survival of

105 otein precursor, A beta PP) in the organized vascular occlusions harvested from patients with this di

106 emodialysis and subsequently develop retinal vascular occlusion have not been examined.

107 Individuals with retinal vascular occlusions have a higher prevalence of dementia

108 Fundus examination revealed diffuse retinal vascular occlusion, hemorrhages clustered along venules,

109 For the proposed definitions of total vascular occlusion, hepatic flow occlusion and inferior

110 mentia was seen in patients with any retinal vascular occlusion (HR, 1.52; confidence interval [CI],

111 Eyes with recent retinal vascular occlusion illustrating paracentral acute middle

112 stem-driven coagulation, both variants block vascular occlusion in an in vivo model for arterial thro

113 and parenchymal destruction with more severe vascular occlusion in grafts from IL-10 -/- recipients.

114 mation (IOI), retinal vasculitis, or retinal vascular occlusion in patients with neovascular age-rela

115 oma, episcleritis and scleritis, and retinal vascular occlusion in patients with SLE deserves vigilan

116 helial proteins is believed to contribute to vascular occlusion in sickle cell disease.

117 of irreversible PEm to ask whether pulmonary vascular occlusion in the absence of reperfusion is itse

118 This was followed by temporary vascular occlusion in the beam path that was resolved by

119 trated noninfectious uveitis and evidence of vascular occlusion in the presence of retinal vascular i

120 oma, episcleritis and scleritis, and retinal vascular occlusion in these patients.

121 ere significantly diminished, and thrombotic vascular occlusion in vivo was significantly blunted in

122 D) is characterized by recurring episodes of vascular occlusion in which neutrophil activation plays

123 Background Retinal vascular occlusion in young adults warrants systematic e

124 suring hemostasis and thrombosis by inducing vascular occlusion in zebrafish larvae.

125 The presence of patent neovessels within vascular occlusions in chronic thromboembolic pulmonary

126 or (G-CSF), each induced NET-mediated lethal vascular occlusions in mice with combined genetic defici

127 ce R rickettsii infection induces thrombotic vascular occlusions in patients with Rocky Mountain Spot

128 we concluded that the extensive formation of vascular occlusions in PD-susceptible grapevines does no

129 ear-resistant adhesions ex vivo and unstable vascular occlusions in vivo.

130 mutation may manifest with combined retinal vascular occlusion involving multiple sites in both eyes

131 Retinal vascular occlusion is considered a risk factor for cardi

132 blood probing during the hyperacute stage of vascular occlusion is crucial to assess the role of infl

133 liferative processes that ultimately lead to vascular occlusion is enhanced by the abnormal metabolic

134 Vascular occlusion is the major cause of morbidity and m

135 nfarction (MI), as a result of thrombosis or vascular occlusion, is the most prevalent cause of morbi

136 of the inner retina, indicating long-lasting vascular occlusion lesions.

137 strategies that target gpIIbIIIa may prevent vascular occlusion, maintain tissue viability, and provi

138 d strategies targeting gpIIbIIIa may prevent vascular occlusion, maintain tissue viability, and provi

139 get platelet adherence molecules may prevent vascular occlusion, maintain tissue viability, and reduc

140 This is a rare presentation of mixed retinal vascular occlusion manifesting as PAMM and incomplete re

141 bed with the following categories: bleeding, vascular occlusion (myocardial infarction, stroke and pu

142 were acute stroke (n = 3), aneurysm (n = 3), vascular occlusion (n = 3), and disk herniation (n = 2).

143 orrhage (n = 7), optic nerve damage (n = 4), vascular occlusions (n = 2), pain (n = 2), eye or head m

144 ) receptors, whereas, in contrast, (3) brief vascular occlusion not associated with appreciable adeno

145 vessel wall is believed to contribute to the vascular occlusion observed in patients with sickle call

146 The intermittent vascular occlusion occurring in sickle cell disease (SCD

147 Thrombotic vascular occlusion occurs in disorders of diverse etiolo

148 n resistance training (BFRT) employs partial vascular occlusion of exercising muscles via inflation c

149 Vascular occlusions of the retina and choroid can cause

150 iuretic peptide, and percentage of pulmonary vascular occlusion on chest computed tomography.

151 ase, such as diabetic retinopathy or retinal vascular occlusion, one would refer to the lesion as PAM

152 n patient populations who experience partial vascular occlusion or altered neuromuscular reflexes.

153 or preventing vertical progression of blood vascular occlusion or endothelial cell death.

154 nce of substantial progression (P=0.008), or vascular occlusion (P=0.005) when compared with the mode

155 Thus, by showing that NETs drive vascular occlusion, pleomorphic necrosis and metastasis,

156 ted blood loss, duration of surgery, hepatic vascular occlusion (rate or duration), portal vein embol

157 Retinal vascular occlusion rates were 1.6% vs 0.5% (KESTREL) and

158 ical dynamics for oxygen, growth factors and vascular occlusions, replicate key clinical observations

159 Thrombotic vascular occlusion resulting in infarction occurs during

160 lead to pathological thrombus formation and vascular occlusion, resulting in stroke, myocardial infa

161 l toxoplasmosis, retinal vasculitis, retinal vascular occlusions, rhegmatogenous and serous retinal d

162 S) had higher risk of developing any retinal vascular occlusion (RR, 2.33; 95% CI, 1.82-3.00), CRAO (

163 d not have higher risk of developing retinal vascular occlusions (RR, 1.01; 95% CI, 0.81-1.26) than m

164 e cases of retinal vasculitis and/or retinal vascular occlusion (RV/RO) were reported, often during t

165 mation, including retinal vasculitis/retinal vascular occlusion (RV/RO).

166 serous retinal detachment (SRD) and retinal vascular occlusion (RVO) are not available.

167 New-onset retinal vascular occlusion (RVO) occurring acutely after messeng

168 terial neointimal formation (quantified by a vascular occlusion score) was more severe in vehicle-tre

169 score, 1.98 +/- 0.02) than in Group PMS5-35 (vascular occlusion score, 0.59 +/- 0.46; p < 0.001).

170 lls was more severe in vehicle-treated rats (vascular occlusion score, 1.98 +/- 0.02) than in Group P

171 Retinal vascular occlusions share the same risk factors as cardi

172 parenchymal infiltration and less prominent vascular occlusion than day 2 murine CTLA4Ig-treated or

173 95% CI, 1.95-5.06) of developing any retinal vascular occlusion than matched controls without SCD.

174 oportion of diabetic retinopathy and retinal vascular occlusions than the group without postoperative

175 vascular endothelium could contribute to the vascular occlusion that characterizes the acute crisis o

176 terial hypertension (PAH), a rare disease of vascular occlusion that leads to high blood pressure in

177 After 7 days, all embolic agents caused vascular occlusion that led to necrosis and fibrosis.

178 Patients develop vascular occlusions that cause cardiovascular, cerebrova

179 This study focuses on vascular occlusions that form in stem secondary xylem of

180 Patients develop painful neuropathy and vascular occlusions that progressively lead to cardiovas

181 Compared to subjects without retinal vascular occlusions, those with retinal vascular occlusi

182 Platelets mediate vascular occlusion through thrombotic functions but are

183 diurnal variation in the time to thrombotic vascular occlusion (TTVO) subsequent to a photochemical

184 Patients who develop thrombotic vascular occlusions usually have underlying vascular dis

185 ques that precipitate acute atherothrombotic vascular occlusion ("vulnerable plaques") are abundant i

186 Retinal vascular occlusion was introduced by rose Bengal and las

187 Vascular occlusion was not permanent, and even when embo

188 However, no risk of retinal vascular occlusion was observed among patients who had r

189 essed vasodilatory response to SNP caused by vascular occlusion was reversed with training.

190 Vascular occlusion was substantially increased when BM-d

191 I), including retinal vasculitis and retinal vascular occlusion, was 11.5% (0.8% and 2.2%) for broluc

192 omocysteine concentration, a risk factor for vascular occlusion, was examined in a representative sam

193 OI, including retinal vasculitis and retinal vascular occlusion, was higher with brolucizumab versus

194 By adjusting the severity of the vascular occlusion, we were able to generate hypertensiv

195 Individuals with and without retinal vascular occlusions were identified by International Cla

196 I), including retinal vasculitis and retinal vascular occlusion, were 9.3% (0.8% and 2.0%) for broluc

197 mong patients with RVO, RAO, and any retinal vascular occlusion, whereas the prevalence of VD is sign

198 cluded patients without a history of retinal vascular occlusion who were diagnosed with COVID-19 infe

199 nically relevant model of stroke utilizing a vascular occlusion with a freshly formed clot, and evalu

200 may be possible to inhibit platelet-mediated vascular occlusion with a minimal effect on primary hemo

201 large areas of splenic necrosis secondary to vascular occlusion with hepatocytes, whereas direct sple

202 na spacing were recorded and correlated with vascular occlusion with logistic regression analysis.

203 involvement (2.0% with vasculitis, 1.4% with vascular occlusion with or without vasculitis).